DossierENTITY

Max Jaderberg

Coverage of Max Jaderberg in the Nexus archive.

Earliest in view: Apr 24 · 17:17 UTCMost recent: Apr 24 · 17:17 UTC

Co-mentioned in this coverage

Recent coverage

HEALTHApr 24 · 17:17 UTCWIRED
AI-Designed Drugs by a DeepMind Spinoff Are Headed to Human Trials
A DeepMind spinoff, Isomorphic Labs, is moving AI-designed drugs into human trials. The company's president, Max Jaderberg, highlighted an 'exciting pipeline of new medicines' at WIRED Health in London.